YANKCOM Partnership’s Charles River Laboratories CRL Stock Holding History

YANKCOM Partnership’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$25.4K	Hold	86	–	–	0.01%	231
2026 Q2	$19.5K	Hold	86	–	–	0.01%	230
2026 Q1	$14.8K	Hold	86	–	–	0.01%	251
2025 Q4	$17.2K	Hold	86	–	–	0.01%	250
2025 Q3	$13.5K	Hold	86	–	–	0.01%	231
2025 Q2	$13K	Buy	86 +67	+353%	+$8.94K	0.01%	226
2025 Q1	$2.86K	Sell	19 -482	-96%	-$80.8K	﹤0.01%	265
2024 Q4	$92.5K	Buy	+501	New	+$96.5K	0.05%	161

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

YANKCOM Partnership's CRL Position: Q3 2026 in Review

YANKCOM Partnership held its Charles River Laboratories (CRL) position steady in Q3 2026 at 86 shares worth $25.4K. The position accounts for 0.01% of the portfolio, ranked #231.

YANKCOM Partnership first reported a position in CRL in Q4 2024 and has held it in 8 quarters since. The position peaked at $92.5K in Q4 2024. 353 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

YANKCOM Partnership held 86 shares of Charles River Laboratories worth $25.4K as of Q3 2026.
YANKCOM Partnership left its Charles River Laboratories share count unchanged in Q3 2026.
Charles River Laboratories made up 0.01% of YANKCOM Partnership's portfolio in Q3 2026, its #231 holding.
YANKCOM Partnership first reported a position in Charles River Laboratories in Q4 2024 and has held it in 8 quarters since.
YANKCOM Partnership's Charles River Laboratories position peaked at $92.5K in Q4 2024.
353 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on YANKCOM Partnership's 13F filing for Q3 2026, filed 15 Oct 2026.